Clinical Trials in Vermont

Vermont is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Vermont and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 32 actively recruiting studies with Vermont sites out of 32 registered in total. The busiest research areas in Vermont are Lung Non-Small Cell Carcinoma, Heart Failure With Preserved Ejection Fraction, Concentric Hypertrophy. Leading sponsors running trials in the state include National Cancer Institute (NCI), Canadian Cancer Trials Group, Children's Oncology Group. By stage, Vermont trials break down as Phase 2 (13), Phase 3 (16), Phase 4 (1).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials

32

Recruiting Now

32

← Back to US Map

Top Conditions in Vermont

Lung Non-Small Cell Carcinoma (2)Heart Failure With Preserved Ejection Fraction (1)Concentric Hypertrophy (1)Primary Central Nervous System Lymphoma (1)Clinical Stage III Cutaneous Melanoma AJCC v8 (1)Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (1)Clinical Stage IV Cutaneous Melanoma AJCC v8 (1)Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (1)Locally Recurrent Head and Neck Squamous Cell Carcinoma (1)Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma (1)Locally Recurrent Laryngeal Squamous Cell Carcinoma (1)Locally Recurrent Oral Cavity Squamous Cell Carcinoma (1)

Frequently Asked Questions — Clinical Trials in Vermont

How many clinical trials are currently recruiting in Vermont?

ClinicalMetric currently tracks 32 actively recruiting clinical trials with at least one location in Vermont. The total number of registered studies—including active but not currently enrolling trials—is 32. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.

What types of clinical trials are available in Vermont?

Vermont hosts clinical trials across a broad range of medical conditions, including Lung Non-Small Cell Carcinoma, Heart Failure With Preserved Ejection Fraction, Concentric Hypertrophy, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Vermont serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.

How do I join a clinical trial near me in Vermont?

To join a clinical trial in Vermont, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Vermont maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Clinical Trials in Vermont

Frequently Asked Questions — Clinical Trials in Vermont

Recruiting Trials in Vermont